An open trial of paroxetine in patients with noncombat-related chronic posttraumatic stress disorder

Journal of Clinical Psychopharmacology

Volumn 18, Issue 1, 1998, Pages 10-18

  Marshall, Randall D ^a,b   Schneier, Franklin R ^a,b   Fallon, Brian A ^a,b   Knight, Charles B G ^b   Abbate, Linda A ^a   Goetz, Deborah ^a   Campeas, Raphael ^a,b   Liebowitz, Michael R ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAL HYDRATE; PAROXETINE;

ADULT; AGITATION; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; CHILDHOOD; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; INTERVIEW; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; STATISTICAL ANALYSIS; STATISTICS;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; FEMALE; HUMANS; MALE; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0031973913     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199802000-00003     Document Type: Article

References (58)

1. Fairbank JA, Schienger WE, Saigh PA, Davidson JRT. An epidemiologic profile of post-traumatic stress disorder: prevalence, comorbidity, and risk factors. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and clinical consequences of stress. Philadelphia: Lippincott-Raven, 1995:415-28.
2. Kessler RC, Sonnega A, Bromet E, Highes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-60.
3. Rothbaum BO, Foa EB. Subtypes of posttraumatic stress disorder and duration of symptoms. In: Davidson JRT, Foa EB, eds. Posttraumatic stress disorder: DSM-IV and beyond. Washington, DC: American Psychiatric Press, 1993:23-36.
4. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55:517-22.
5. Davidson J, Kudler H, Smith R, Mahorney SL, Upper S, Hammett E, Saunders WB, Cavenar JL Jr. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 1990;47:259-66.
6. Frank JB, Kosten TR, Giller EL, Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry 1988;1145:1289-91.
7. Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 1991;179:366-70.
8. Reist C, Kauffman CD, Haier RJ. A controlled trial of desipramine in 18 men with post-traumatic stress disorder. Am J Psychiatry 1976;146:513-6.
9. Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Res 1988; 24:149-55.
10. Braun P, Greenberg D, Dasberg H, Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990;51:236-8.
11. Katz RJ, Lott MH, Arbus P, Crocq L, Ungjaerde O, Lopez G, Loughrey GC, MacFarlane DJ, Nugent D, Turner SW, Weisaeth L, Yule W. Pharmacotherapy of posttraumatic stress disorder with a novel psychotropic. Anxiety 1995;1:169-74.
12. 11a. Kaplan Z, Amir M, Swartz M, Levine J. Inositol treatment of posttraumatic stress disorder. Anxiety 1996;2:51-2.
13. Marshall RD, Stein DJ, Liebowitz MR, Yehuda R. A pharmacotherapy algorithm in the treatment of posttraumatic stress disorder. Psychiatr Ann 1996;26:217-26.
14. Prudic J, Haskett RF, Mulsant B, Malone KM, Pettinati HM, Stephens S, Greenberg R, Rifas SL, Sackeim HA. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996;153:985-92.
15. Davidson J, Roth S, Newman E. Fluoxetine in post-traumatic stress disorder. J Trauma Stress 1990;4:419-23.
16. De Boer M, Op den Velde W, Falger PJ, Hovens JE, De Groen JH, Van Duijn H. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom 1992;57:158-63.
17. Kline NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder [letter]. Am J Psychiatry 1994;151:621.
18. McDougle CJ, Southwick SM, Charney DS, St. James RL. An open trial of fluoxetine in the treatment of posttraumatic stress disorder [letter], J Clin Psychopharmacol 1991;11:325-7.
19. Nagy LM, Morgan CA III, Southwick SM, Charney DS. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993;13:107-13.
20. Shay J. Fluoxetine reduces explosiveness and elevates mood of Vietnam combat vets with PTSD. J Trauma Stress 1992;5:97-101.
21. Burdon AP, Sutker PB, Foulks EF, Crane M, Thompson KE. Pilot program of treatment for PTSD [letter]. Am J Psychiatry 1991; 148:1269-70.
22. Marshall RD, Klein DF. Pharmacotherapy in the treatment of posttraumatic stress disorder. Psychiatr Ann 1995;25:588-597.
23. Hertzberg MA, Feldman ME, Beckham JC, Davidson JRT. Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. J Clin Psychopharmacol 1996;16:294-8.
24. Rothbaum BO, Ninan PT, Thomas L. Sertraline in the treatment of rape victims with posttraumaic stress disorder. J Trauma Stress 1996;9:865-72.
25. Nagy LM, Southwick SM, Charney DS. Placebo-controlled trial of fluoxetine in PTSD. Poster presentation, International Society for Traumatic Stress Studies, 12th Annual Meeting, San Francisco, CA, November 11, 1996.
26. Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC. Paroxetine versus placebo: a double-bund comparison in depressed patients. J Clin Psychiatry 1992;53:434-8.
27. Dunbar GC, Cohn JB, Fabre LF, Feighner JP, Fieve RR, Mendels J, Shrivastava RK. A comparison of paroxetine, imipramine and placebo in depressed outpatients. Br J Psychiatry 1991;159:394-8.
28. Dunbar GC, Fuell DL. The anti-anxiety and anti-agitation effects of paroxetine in depressed patients. Int Clin Psychopharmacol 1992;6[suppl 4]:81-90.
29. De Wilde J, Spiers R, Mertens C, Bartholome F, Schotte G, Leyman S. A double blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiatr Scand 1993;87:141-5.
30. Sheehan D, Dunbar GC, Fuell DL. The effect of paroxetine on anxiety and agitation associated with depression. Psychopharmacol Bull 1992;28:139-43.
31. Yehuda R, Giller EL, Mason JW. Psychoneuroendocrine assessment of posttraumatic stress disorder, current progress and new directions. Prog Neuropsychopharmacol Biol Psychiatry 1994;55:517-22.
32. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996;40:79-88.
33. Resnick HS, Kilpatrick DG, Best CL, Kramer TL. Vulnerability-stress factors in development of posttraumatic stress disorder. J Nerv Ment Dis 1992;180:424-30.
34. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979;41:209-18.
35. Davidson JRT, Book SW, Colket JT, Tupler LA, Roth S, David D, Hertberg M, Mellman T, Beckham JC, Smith RD, Davison RM, Katz R, Feldman ME. Assessment of a new self-rating scale for posttraumatic stress disorder the Davidson Trauma Scale. Psychol Med 1997;27:153-60.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
37. Hamilton M. Diagnosis and ratings of anxiety. Br J Psychiatry 1969;3:76-9.
38. Maier W, Buller R, Philipp M, Heuser L. The Hamilton anxiety scale: reliability, validity, and sensitivity to change in anxiety and depressive disorders. J Affect Disord 1988;14:61-8.
39. Derogatis LR. SCL-90: administration, scoring, and procedure manual. Baltimore: Johns Hopkins University Press, 1977.
40. Briere J, Runtz M. Augmenting Hopkins SCL scales to measure dissociative symptoms: data from two nonclinical samples. J Pers Assess 1990;55:376-9.
41. Sheehan J. The anxiety disease. New York: Harper & Row, 1983.
42. Bremner JD, Southwick SM, Johnson DR, Yehuda R, Charney DS. Childhood physical abuse and combat-related posttraumatic stress disorder in Vietnam veterans. Am J Psychiatry 1993;150:235-9.
43. Zaidi LY, Foy DW. Childhood abuse and combat-related PTSD. J Trauma Stress 1991;4:325-43.
44. Riggs DS, Rothbaum BO, Foa EB. A prospective examination of symptoms of posttraumatic stress disorder in victims of nonsexual assault. J Interpers Violence 1995;10:201-14.
45. Yehuda R, Elkin A, Binder-Brynes K, Kahana B, Southwick SM, Schmeidler J, Giller EL. Dissociation in aging Holocaust survivors. Am J Psychiatry 1996;153:935-40.
46. Foa EB, Davidson J, Rothbaum BO. Posttraumatic stress disorder. In: Gabbard GO, ed. Treatments of psychiatric disorders. 2nd ed. Washington, DC: American Psychiatric Press, 1995: 1499-35.
47. North CS, Smith EM, Spitznagel EL. Posttraumatic stress disorder in survivors of a mass shooting. Am J Psychiatry 1994;151:82-8.
48. Davidson JRT, Hughes D, Blazer DG, George LK. Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med 1991;21:713-21.
49. Kulka RA, Schlenger WE, Fairbank JA, Hough RL, Jordan BK, Marmar CR, Weiss D. Trauma and the Vietnam War generation: report of findings from the National Vietnam Veterans Readjustment Study. New York: Brunner/Mazel, 1990.
50. Heizer JE, Robins LN, McEvoy L. Post-traumatic stress disorder in the general population: findings of the epidemiologic catchment area survey. N Engl J Med 1987;317:1630-4.
51. Foa EB, Rothbaum BO, Riggs DS, Murdock TB. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol 1991;59:715-23.
52. Brom D, Kleber RJ, Defares PB. Brief psychotherapy for posttraumatic stress disorders. J Consult Clin Psychol 1989;57:607-12.
53. Veronen LJ, Kilpatric DG. Stress management for rape victims. In: Meichenbaum D, Jaremko ME, eds. Stress reduction and prevention. New York: Plenum Press, 1983:341-74.
54. Pitman RK, Altman B, Greenwald E, Longpre RE, Macklin ML, Poire RE, Steketee G. Psychiatric complications during flooding therapy for posttraumatic stress disorder. J Clin Psychiatry 1991;52:17-20.
55. Foa EB, Riggs DS. Post-traumatic stress disorder in rape victims. In: Oldham J, Riba MB, Tasman A, eds. American Psychiatric Press review of psychiatry, vol. 12. Washington, DC: American Psychiatric Press, 1993:273-303.
56. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994;15:220-6.
57. Cooper JR, Bloom FE, Roth RH. Serotonin (5-hydroxytryptamine) and histamine. In: The biochemical basis of neuropharmacology. 7th ed. New York: Oxford University Press, 1996:352-409.
58. De Souza EB, Grigoriadis DE. Corticotropin-releasing factor: physiology, pharmacology, and role in central nervous system and immune disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fourth generation of progress. Philadelphia: Lippincott-Raven, 1995:505-18.